Home › Atrial Fibrillation › Arizona › Phoenix
Atrial Fibrillation clinical trials in Phoenix, AZ
5 studies for Atrial Fibrillation are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
Recruiting
- Phoenix Cardiovascular Research Group, Phoenix
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
RecruitingPhase 3
- Banner University, Phoenix
Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
Recruiting
- Banner University Med Ctr, Phoenix
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
RecruitingPhase 3
- Anthos Investigative Site 9906, Phoenix
Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
RecruitingPhase 3
- The University of Arizona College of Medicine- Phoenix, Phoenix
About Atrial Fibrillation
Atrial fibrillation (AF or AFib) is the most common type of arrhythmia (irregular heartbeat). Read about symptoms and treatment.
More about Atrial Fibrillation on MedlinePlus
Atrial Fibrillation trials in other cities
- Boston, MA19 studies
- New York City, NY19 studies
- Atlanta, GA17 studies
- Cleveland, OH17 studies
- Jonesboro, AR13 studies
- Pittsburgh, PA12 studies
- Philadelphia, PA12 studies
- Ann Arbor, MI12 studies
- Chicago, IL12 studies
- Orlando, FL11 studies
- Cincinnati, OH10 studies
- Austin, TX10 studies
Other studies in Phoenix
- Breast Cancer25 studies
- Colorectal Cancer24 studies
- Non-Small Cell Lung Cancer21 studies
- Metastatic Cancer19 studies
- Obesity19 studies
- Pancreatic Cancer18 studies
- Cancer (all types)17 studies
- Cardiovascular Disease16 studies
- Prostate Cancer16 studies
- Multiple Myeloma16 studies
- Heart Failure16 studies
- Alzheimer's Disease15 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.